Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Blockchain's potential to improve clinical trials-an essay by Leeza Osipenko.

Osipenko L.

BMJ. 2019 Oct 3;367:l5561. doi: 10.1136/bmj.l5561. No abstract available.

PMID:
31582404
2.

Young people's preferences for the use of emerging technologies for asymptomatic regular chlamydia testing and management: a discrete choice experiment in England.

Eaton S, Biggerstaff D, Petrou S, Osipenko L, Gibbs J, Estcourt CS, Sadiq T, Szczepura A.

BMJ Open. 2019 Jan 29;9(1):e023663. doi: 10.1136/bmjopen-2018-023663.

3.

Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.

Crispi F, Naci H, Barkauskaite E, Osipenko L, Mossialos E.

Appl Health Econ Health Policy. 2019 Apr;17(2):189-211. doi: 10.1007/s40258-018-0438-y.

PMID:
30367349
4.

A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness.

Anderson M, Naci H, Morrison D, Osipenko L, Mossialos E.

J Clin Epidemiol. 2019 Jan;105:50-59. doi: 10.1016/j.jclinepi.2018.09.003. Epub 2018 Sep 18. Review.

PMID:
30236484
5.

The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.

Tafuri G, Lucas I, Estev√£o S, Moseley J, d'Andon A, Bruehl H, Gajraj E, Garcia S, Hedberg N, Massari M, Molina A, Obach M, Osipenko L, Petavy F, Petschulies M, Pontes C, Russo P, Schiel A, Van de Casteele M, Zebedin-Brandl EM, Rasi G, Vamvakas S.

Br J Clin Pharmacol. 2018 May;84(5):1013-1019. doi: 10.1111/bcp.13524. Epub 2018 Mar 5.

6.

Regulatory watch: Outcomes of early health technology assessment dialogues in medicinal product development.

Maignen F, Osipenko L, Pinilla-Dominguez P, Crowe E.

Nat Rev Drug Discov. 2017 Feb 2;16(2):79. doi: 10.1038/nrd.2016.286. No abstract available.

PMID:
28148947
7.

Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice.

Maignen F, Osipenko L, Pinilla-Dominguez P, Crowe E.

Eur J Clin Pharmacol. 2017 Mar;73(3):297-305. doi: 10.1007/s00228-016-2174-2. Epub 2016 Dec 10.

PMID:
27942759
8.

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice.

Tafuri G, Pagnini M, Moseley J, Massari M, Petavy F, Behring A, Catalan A, Gajraj E, Hedberg N, Obach M, Osipenko L, Russo P, Van De Casteele M, Zebedin EM, Rasi G, Vamvakas S.

Br J Clin Pharmacol. 2016 Oct;82(4):965-73. doi: 10.1111/bcp.13023. Epub 2016 Jul 1.

9.

NICE supports allowing technology assessment bodies to provide advice to drug industry.

Longson C, Crabb N, Osipenko L.

BMJ. 2014 Aug 13;349:g5035. doi: 10.1136/bmj.g5035. No abstract available.

PMID:
25121499
10.

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Szczepura A, Osipenko L, Freeman K.

BMC Pregnancy Childbirth. 2011 Jan 18;11:5. doi: 10.1186/1471-2393-11-5.

11.

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.

Freeman K, Szczepura A, Osipenko L.

Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):91-8. doi: 10.1016/j.ejogrb.2008.10.010. Epub 2008 Dec 9. Review.

PMID:
19081172
12.

Fetal RHD typing: Is fetal RHD typing in all RhD negative women cost effective?

Szczepura A, Bonsel G, Krauth C, Osipenko L, Haverkamp A.

BMJ. 2008 Apr 26;336(7650):906. doi: 10.1136/bmj.39556.499549.80. No abstract available.

13.

Quality of Rh genotyping studies and diagnostic accuracy estimation.

Freeman K, Szczepura A, Osipenko L.

Am J Obstet Gynecol. 2007 Jul;197(1):116-7; author reply 117-8. No abstract available.

PMID:
17618787
14.

Application of ELI-P-complex method in clinical obstetrics.

Poletaev AB, Maltseva LI, Zamaleeva RS, Nukhnin MA, Osipenko LG.

Am J Reprod Immunol. 2007 Apr;57(4):294-301.

PMID:
17362391
15.

General network of natural autoantibodies as immunological homunculus (Immunculus).

Poletaev A, Osipenko L.

Autoimmun Rev. 2003 Sep;2(5):264-71. Review.

PMID:
12965177

Supplemental Content

Loading ...
Support Center